Beta-blocker to reduce heart damage after brain bleed
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether a common beta-blocker (metoprolol) can protect the heart from injury and reduce inflammation after a bleed in the brain (subarachnoid hemorrhage). It may help patients recover better after this type of stroke.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had a confirmed, non-traumatic brain bleed (subarachnoid hemorrhage).
- You are over 18 years old.
- You are not currently pregnant.
- Your vital signs (blood pressure and heart rate) are stable enough to safely take a beta-blocker.
- You do not have severe heart failure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a type of blood pressure medication (a non-selective beta blocker) can improve recovery in adults with severe traumatic brain injury. It may help by reducing stress on the brain after injury.
This trial tests whether a common antiplatelet medicine can reduce the risk of future heart attacks, strokes, or blood clots in people who have had a brain bleed. It's for adults who had their first brain bleed and can start treatment within 3 months of the stroke.
This study tests whether a heart medication called propranolol, given intravenously (through an IV), can prevent serious infections in patients who have had bleeding in the brain. You would receive this treatment within 24 hours of your stroke symptoms starting.
This trial tests whether giving a beta blocker drug after a moderate or severe traumatic brain injury can improve recovery. It is for patients who have a brain injury but only minor or no other injuries.
This trial is testing whether giving a beta-blocker medication (metoprolol) early after a heart attack can help people who have a fast heart rate or low blood pressure but no signs of organ failure. The goal is to see if this treatment improves recovery.
This trial tests if a beta-blocker medicine can help people with a recently diagnosed brain aneurysm that cannot be treated with surgery or a catheter procedure. It aims to see if the drug reduces the risk of the aneurysm growing or rupturing.
Hear when a new Non-Traumatic Subarachnoid Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.